Artemisia scoparia enhances adipocyte development and endocrine function in vitro and enhances insulin action in vivo

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Richard, Allison J ^a   Fuller, Scott ^a   Fedorcenco, Veaceslav ^a   Beyl, Robbie ^a   Burris, Thomas P ^b   Mynatt, Randall ^a   Ribnicky, David M ^c   Stephens, Jacqueline M ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALCOHOL; ARTEMISIA SCOPARIA EXTRACT; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; INSULIN SENSITIZING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLANT EXTRACT; PROTEIN; ROSIGLITAZONE; TRANSCRIPTION FACTOR GAL4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ADIPOCYTOKINE; GLUCOSE BLOOD LEVEL;

3T3 CELL LINE; ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY COMPOSITION; BODY WEIGHT; C57BL 6 MOUSE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; ENDOCRINE FUNCTION; ENZYME PHOSPHORYLATION; EPIDIDYMIS FAT; FOOD INTAKE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLUCOSE BLOOD LEVEL; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LIPID DIET; LIPID STORAGE; LUCIFERASE ASSAY; MALE; MOUSE MUTANT; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; RECEPTOR BINDING ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; ANIMAL; ARTEMISIA; BLOOD; CELL LINE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; ENDOCRINE SYSTEM; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOUSE; SECRETION (PROCESS);

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ADIPOKINES; ADIPONECTIN; ADIPOSE TISSUE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ARTEMISIA; BLOOD GLUCOSE; BODY COMPOSITION; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCRINE SYSTEM; GENE EXPRESSION REGULATION; HUMANS; INSULIN; MALE; MICE; PLANT EXTRACTS; PPAR GAMMA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84902579064     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098897     Document Type: Article

References (47)

1. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE (2001) The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7: 947-953. 10.1038/90992 [doi];90992 [pii].
2. Mantzoros CS (1999) The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med 130: 671-680. 199904200-00008 [pii].
3. Sun K, Kusminski CM, Scherer PE (2011) Adipose tissue remodeling and obesity. J Clin Invest 121: 2094-2101. 45887 [pii];10.1172/JCI45887 [doi].
4. Danforth E Jr (2000) Failure of adipocyte differentiation causes type II diabetes mellitus? Nat Genet 26: 13. 10.1038/79111 [doi].
5. Kim JY, van de Wall E, Laplante M, Azzara A, Trujillo ME, et al. (2007) Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 117: 2621-2637. 10.1172/JCI31021 [doi]. (Pubitemid 47494363)
6. Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, et al. (2005) Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 46: 2347-2355. M500294-JLR200 [pii];10.1194/jlr.M500294-JLR200 [doi].
7. Ribnicky DM, Poulev A, Watford M, Cefalu WT, Raskin I (2006) Antihyperglycemic activity of Tarralin, an ethanolic extract of Artemisia dracunculus L. Phytomedicine 13: 550-557. S0944-7113(05)00210-2 [pii];10.1016/j.phymed.2005.09.007 [doi].
8. Xing XH, Zhang ZM, Hu XZ, Wu RQ, Xu C (2009) Antidiabetic effects of Artemisia sphaerocephala Krasch. gum, a novel food additive in China, on streptozotocin-induced type 2 diabetic rats. J Ethnopharmacol 125: 410-416. S0378-8741(09)00453-X [pii];10.1016/j.jep.2009.07.021 [doi].
9. Lim DW, Kim YT, Jang YJ, Kim YE, Han D (2013) Anti-obesity effect of Artemisia capillaris extracts in high-fat diet-induced obese rats. Molecules 18: 9241-9252. molecules18089241 [pii];10.3390/molecules18089241 [doi].
10. Yamamoto N, Kanemoto Y, Ueda M, Kawasaki K, Fukuda I, et al. (2011) Antiobesity and anti-diabetic effects of ethanol extract of Artemisia princeps in C57BL/6 mice fed a high-fat diet. Food Funct 2: 45-52. 10.1039/ c0fo00129e[doi].
11. Hamza N, Berke B, Cheze C, Agli AN, Robinson P, et al. (2010) Prevention of type 2 diabetes induced by high fat diet in the C57BL/6J mouse by two medicinal plants used in traditional treatment of diabetes in the east of Algeria. J Ethnopharmacol 128: 513-518. S0378-8741(10)00020-6 [pii];10.1016/j.jep.2010.01.004 [doi].
12. Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM (2000) Transcriptional regulation of adipogenesis. Genes Dev 14: 1293-1307. (Pubitemid 30397073)
13. Busby SA, Kumar N, Kuruvilla DS, Istrate MA, Conkright JJ, et al. (2011) Identification of a novel non-retinoid pan inverse agonist of the retinoic acid receptors. ACS Chem Biol 6: 618-627. 10.1021/cb100396s [doi].
14. Kumar N, Solt LA, Conkright JJ, Wang Y, Istrate MA, et al. (2010) The benzenesulfoamide T0901317 [N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1- hydroxy-1-(trifluoromethyl)ethy l]phenyl]-benzenesulfonamide] is a novel retinoic acid receptor-related orphan receptor-alpha/gamma inverse agonist. Mol Pharmacol 77: 228-236. mol.109.060905 [pii];10.1124/mol.109.060905 [doi].
15. Solt LA, Wang Y, Banerjee S, Hughes T, Kojetin DJ, et al. (2012) Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists. Nature 485: 62-68. nature11030 [pii];10.1038/nature11030 [doi].
16. Green H, Kehinde O (1975) An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell 5: 19-27. 0092-8674(75)90087-2 [pii].
17. Richard AJ, Amini ZJ, Ribnicky DM, Stephens JM (2012) St. John's Wort inhibits insulin signaling in murine and human adipocytes. Biochim Biophys Acta 1822: 557-563. S0925-4439(11)00283-3 [pii];10.1016/j.bbadis.2011.12.005 [doi].
18. Kuri-Harcuch W, Green H (1978) Adipose conversion of 3T3 cells depends on a serum factor. Proc Natl Acad Sci U S A 75: 6107-6109. (Pubitemid 9093671)
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419. (Pubitemid 15018832)
20. Frosig C, Jensen TE, Jeppesen J, Pehmoller C, Treebak JT, et al. (2013) AMPK and insulin action - responses to ageing and high fat diet. PLoS One 8: e62338. 10.1371/journal.pone.0062338 [doi];PONE-D-12-39704 [pii].
21. Bruun JM, Lihn AS, Verdich C, Pedersen SB, Toubro S, et al. (2003) Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 285: E527-E533. 10.1152/ajpendo.00110.2003 [doi];00110.2003 [pii].
22. Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87-91. (Pubitemid 23036092)
23. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95: 2409-2415. 10.1172/JCI117936 [doi].
24. Sartipy P, Loskutoff DJ (2003) Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A 100: 7265-7270. 10.1073/pnas.1133870100 [doi];1133870100 [pii].
25. Ruderman NB, Carling D, Prentki M, Cacicedo JM (2013) AMPK, insulin resistance, and the metabolic syndrome. J Clin Invest 123: 2764-2772. 67227 [pii];10.1172/JCI67227 [doi].
26. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, et al. (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8: 1288-1295. 10.1038/nm788 [doi];nm788 [pii].
27. Brazil DP, Hemmings BA (2001) Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem Sci 26: 657-664. S0968-0004(01)01958-2 [pii].
28. Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, et al. (1999) PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 4: 611-617. S1097-2765(00)80211-7 [pii].
29. DeFronzo RA, Tripathy D, Schwenke DC, Banerji M, Bray GA, et al. (2011) Pioglitazone for diabetes prevention in impaired glucose tolerance. N Engl J Med 364: 1104-1115. 10.1056/NEJMoa1010949 [doi].
30. Tripathy D, Daniele G, Fiorentino TV, Perez-Cadena Z, Chavez-Velasquez A, et al. (2013) Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3-TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study. Diabetologia 56: 2153-2163. 10.1007/s00125-013-2976-z [doi].
31. Huang JV, Greyson CR, Schwartz GG (2012) PPAR-gamma as a therapeutic target in cardiovascular disease: evidence and uncertainty. J Lipid Res 53: 1738-1754. jlr.R024505 [pii];10.1194/jlr.R024505 [doi].
32. Nissen SE, Wolski K (2007) Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356: 2457-2471. NEJMoa072761 [pii];10.1056/NEJMoa072761 [doi].
33. Rubenstrunk A, Hanf R, Hum DW, Fruchart JC, Staels B (2007) Safety issues and prospects for future generations of PPAR modulators. Biochim Biophys Acta 1771: 1065-1081. S1388-1981(07)00035-2 [pii];10.1016/j.bbalip.2007.02.003 [doi].
34. Choi JH, Banks AS, Kamenecka TM, Busby SA, Chalmers MJ, et al. (2011) Antidiabetic actions of a non-agonist PPARgamma ligand blocking Cdk5-mediated phosphorylation. Nature 477: 477-481. nature10383 [pii];10.1038/nature10383 [doi].
35. Choi JH, Banks AS, Estall JL, Kajimura S, Bostrom P, et al. (2010) Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5. Nature 466: 451-456. nature09291 [pii];10.1038/nature09291 [doi].
36. Donath MY, Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11: 98-107. nri2925 [pii];10.1038/nri2925 [doi].
37. Whitehead JP, Richards AA, Hickman IJ, Macdonald GA, Prins JB (2006) Adiponectin - a key adipokine in the metabolic syndrome. Diabetes Obes Metab 8: 264-280. DOM510 [pii];10.1111/j.1463-1326.2005.00510.x [doi].
38. Fasshauer M, Kralisch S, Klier M, Lossner U, Bluher M, et al. (2003) Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 301: 1045-1050. S0006291X03000901 [pii].
39. Rotter V, Nagaev I, Smith U (2003) Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factoralpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 278: 45777-45784. 10.1074/jbc.M301977200 [doi];M301977200 [pii].
40. Bijland S, Mancini SJ, Salt IP (2013) Role of AMP-activated protein kinase in adipose tissue metabolism and inflammation. Clin Sci (Lond) 124: 491-507. CS20120536 [pii];10.1042/CS20120536 [doi].
41. Chopra I, Li HF, Wang H, Webster KA (2012) Phosphorylation of the insulin receptor by AMP-activated protein kinase (AMPK) promotes ligand-independent activation of the insulin signalling pathway in rodent muscle. Diabetologia 55: 783-794. 10.1007/s00125-011-2407-y [doi].
42. Shibata T, Takaguri A, Ichihara K, Satoh K (2013) Inhibition of the TNF-alpha-induced serine phosphorylation of IRS-1 at 636/639 by AICAR. J Pharmacol Sci 122: 93-102. DN/JST.JSTAGE/jphs/12270FP [pii].
43. Daval M, Foufelle F, Ferre P (2006) Functions of AMP-activated protein kinase in adipose tissue. J Physiol 574: 55-62. jphysiol.2006.111484 [pii];10.1113/jphysiol.2006.111484 [doi].
44. Obanda DN, Hernandez A, Ribnicky D, Yu Y, Zhang XH, et al. (2012) Bioactives of Artemisia dracunculus L. mitigate the role of ceramides in attenuating insulin signaling in rat skeletal muscle cells. Diabetes 61: 597-605. db11-0396 [pii];10.2337/db11-0396 [doi].
45. Wang ZQ, Ribnicky D, Zhang XH, Raskin I, Yu Y, et al. (2008) Bioactives of Artemisia dracunculus L enhance cellular insulin signaling in primary human skeletal muscle culture. Metabolism 57: S58-S64. S0026-0495(08)00100-5 [pii];10.1016/j.metabol.2008.04.003 [doi].
46. Wang ZQ, Ribnicky D, Zhang XH, Zuberi A, Raskin I, et al. (2011) An extract of Artemisia dracunculus L. enhances insulin receptor signaling and modulates gene expression in skeletal muscle in KK-A(y) mice. J Nutr Biochem 22: 71-78. S0955-2863(10)00009-4 [pii];10.1016/j.jnutbio.2009.11.015 [doi].
47. Wang ZQ, Zhang XH, Yu Y, Tipton RC, Raskin I, et al. (2013) Artemisia scoparia extract attenuates non-alcoholic fatty liver disease in diet-induced obesity mice by enhancing hepatic insulin and AMPK signaling independently of FGF21 pathway. Metabolism 62: 1239-1249. S0026-0495(13)00084-X [pii];10.1016/j.metabol.2013.03.004 [doi].